Pasadena, CA, United States of America

Konstantin Taganov

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 23(Granted Patents)


Location History:

  • Pasadena, CA (US) (2014 - 2019)
  • San Diego, CA (US) (2019 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovations of Konstantin Taganov

Introduction

Konstantin Taganov is a prominent inventor based in Pasadena, California. He has made significant contributions to the field of biomedical research, particularly in the area of microRNA and its implications for treating various disorders. With a total of six patents to his name, Taganov's work has garnered attention for its potential impact on healthcare.

Latest Patents

Among his latest patents, Taganov has developed methods for microRNA inhibition aimed at treating inflammation and myeloproliferative disorders. His research highlights the role of microRNA-155 in inflammation, hematopoiesis, and myeloproliferation. The patents disclose methods and compositions for diagnosing and treating these disorders by modulating the expression levels of specific genes, including Cutl1, Arntl, Picalm, Jarid2, PU.1, Csf1r, HIF1α, Sla, Cebpβ, and Bach1.

Career Highlights

Taganov is affiliated with the California Institute of Technology, where he continues to advance his research. His innovative approaches have positioned him as a key figure in the study of microRNA and its therapeutic applications. His work not only contributes to scientific knowledge but also holds promise for developing new treatment strategies.

Collaborations

Throughout his career, Taganov has collaborated with notable scientists, including David Baltimore and Mark Boldin. These partnerships have enriched his research and expanded the scope of his innovations.

Conclusion

Konstantin Taganov's contributions to the field of biomedical research through his patents and collaborations underscore his role as a leading inventor. His work on microRNA inhibition has the potential to transform treatment options for inflammation and myeloproliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…